Literature DB >> 7516856

Selecting appropriate antihypertensive drug dosages.

G D Johnston1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7516856     DOI： 10.2165/00003495-199447040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  60 in total

1.  Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).

Authors:  J Meekers; A Missotten; R Fagard; D Demuynck; C Harvengt; P Pas; L Billiet; A Amery
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-02

2.  Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.

Authors:  A J Marshall; D W Barritt; J D Harry
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

3.  Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertension.

Authors:  C L Curry; S M Janda; R Harris; J H MacKay; C A Nugent; J Ryan; H Schnaper; J Schoenberger
Journal:  Clin Ther       Date:  1986       Impact factor: 3.393

4.  Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: identification of triphasic pattern of blood pressure response.

Authors:  D B Case; S A Atlas; J H Laragh; P A Sullivan; J E Sealey
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

5.  The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents.

Authors:  J Conway; J Johnston; A Coats; V Somers; P Sleight
Journal:  J Hypertens       Date:  1988-02       Impact factor: 4.844

6.  Management of malignant hypertension complicated by renal insufficiency.

Authors:  J W Woods; W B Blythe
Journal:  N Engl J Med       Date:  1967-07-13       Impact factor: 91.245

7.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

Authors:  A P Douglas-Jones; J M Cruickshank
Journal:  Br Med J       Date:  1976-04-24

8.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

9.  Dose response in captopril therapy of hypertension.

Authors:  P Lijnen; R Fagard; J Staessen; L J Verschueren; A Amery
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

10.  Efficacy and tolerance of spironolactone in essential hypertension.

Authors:  X Jeunemaitre; G Chatellier; C Kreft-Jais; A Charru; C DeVries; P F Plouin; P Corvol; J Menard
Journal:  Am J Cardiol       Date:  1987-10-01       Impact factor: 2.778
View more
  4 in total

Review 1.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

2.  Redefining the ACE-inhibitor dose-response relationship: substantial blood pressure lowering after massive doses.

Authors:  G A Christie; C Lucas; D N Bateman; W S Waring
Journal:  Eur J Clin Pharmacol       Date:  2006-11-07       Impact factor: 2.953

Review 3.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

Review 4.  Epidemiology of stroke. Importance of preventive pharmacological strategies in elderly patients and associated costs.

Authors:  I Kawachi
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.